NCT07691541

Brief Summary

Quality improvement (QI) initiative to improve uptake and utilization of Connected MOM, particularly among those with limited access to health care

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for not_applicable

Timeline
39mo left

Started Jul 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jul 2026Oct 2029

First Submitted

Initial submission to the registry

May 22, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 9, 2026

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2029

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2029

Last Updated

July 9, 2026

Status Verified

July 1, 2026

Enrollment Period

3 years

First QC Date

May 22, 2026

Last Update Submit

July 2, 2026

Conditions

Keywords

maternal and infant healthprenatal carepostpartum follow-up

Outcome Measures

Primary Outcomes (5)

  • Successful use of the intervention and control programs measured by enrollment aggregate

    Aggregate enrollment in the intervention or control arms by 25 weeks of gestation relative to the total number of eligible participants. This will be measured by the total number of women participating in the Connected MOM or Connected MOM+ divided by the total number of eligible pregnant women presenting to the hospital.

    6-9 months

  • Successful use of the intervention and control programs as determined by the systolic and diastolic blood pressure measurements

    This is determined by measuring the systolic and diastolic blood pressure in mmHg at least once per week during pregnancy.

    6-9 months

  • Successful use of the intervention and control programs as determined by postpartum blood pressure measurement

    This is determined by measuring at least one postpartum blood pressure measurement (systolic and diastolic) in mmHg before a postpartum visit.

    6-9 months

  • Adequacy of prenatal care

    Adequacy of prenatal care will be measured using the Kotelchuck index, a score that assesses the adequacy of maternal health care. The score ranges from 0% to above, with higher scores indicating better maternal health care.

    6-9 months

  • Adverse composite maternal outcome

    pre-eclampsia without severe features (\~5%), pre-eclampsia with severe features (1-2%), HELLP syndrome; eclampsia (rare), preterm delivery \< 37 weeks (spontaneous or indicated) (12-15%), SMM without transfusion included (around 2-3%), maternal mortality

    6-9 months

Secondary Outcomes (5)

  • Reach

    6-9 months

  • Sustainability

    6-9 months

  • Engagement

    6-9 months

  • Retention

    6-9 months

  • Attendance of a postpartum visit

    6-9 months

Study Arms (2)

Intervention - CM+

ACTIVE COMPARATOR

Navigator support to enroll and use Connected MOM

Other: Connected MOM +

Control - CM

NO INTERVENTION

Standard protocol for offering Connected MOM

Interventions

Navigator support to encourage enrollment, consistent use, and postpartum follow-up in Connected MOM program

Intervention - CM+

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Access to a smartphone
  • Understanding of English or Spanish in oral and written discourses
  • Have a participating Ochsner-employed provider
  • Plan to deliver at a participating Ochsner hospital
  • Reside in a zip code served by the participating clinics

You may not qualify if:

  • Provider feels that study participation is not in patient's best interest
  • Does not understand English or Spanish well enough to follow recommendations
  • Plans to move from the study area served by the participating clinics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ochsner Health

New Orleans, Louisiana, 70121, United States

Location

MeSH Terms

Conditions

Toxemia

Condition Hierarchy (Ancestors)

Infections

Study Officials

  • Emily W Harville, PhD

    Tulane University Weatherhead School of Public Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Emily W Harville, PhD

CONTACT

Sherri M Longo, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Statistician
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Cluster-randomized
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2026

First Posted

July 9, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

July 1, 2029

Study Completion (Estimated)

October 1, 2029

Last Updated

July 9, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Data are covered by HIPAA

Locations